1
Novartis AG
0 1 2 3 4 5
3.73
2
GSK plc
0 1 2 3 4 5
3.71
3
Bayer AG
0 1 2 3 4 5
3.36
4
Sanofi
0 1 2 3 4 5
3.35
5
Boehringer Ingelheim
0 1 2 3 4 5
3.33
6
Takeda Pharmaceutical Co, Ltd
0 1 2 3 4 5
3.19
7
AstraZeneca plc
0 1 2 3 4 5
3.18
8
Roche Holding AG
0 1 2 3 4 5
3.14
9
Merck KGaA
0 1 2 3 4 5
3.04
10
Novo Nordisk A/S
0 1 2 3 4 5
3.02
11
Pfizer Inc
0 1 2 3 4 5
2.99
12
Eisai Co, Ltd
0 1 2 3 4 5
2.38
13
Bristol Myers Squibb
0 1 2 3 4 5
2.21
13
Gilead Sciences
0 1 2 3 4 5
2.21
15
Johnson & Johnson
0 1 2 3 4 5
2.13
16
Astellas Pharma Inc
0 1 2 3 4 5
2.02
17
Merck & Co, Inc
0 1 2 3 4 5
1.79
18
Eli Lilly & Co
0 1 2 3 4 5
1.49
19
Daiichi Sankyo Co, Ltd
0 1 2 3 4 5
1.45
20
AbbVie Inc
0 1 2 3 4 5
1.26
0 1 2 3 4 5

The ranking above shows the position and score of each company in the 2026 Index (left) and 2024 Index (right). Click on a company's name to go to its full report card.